Results

eNauka >  Results >  Real world data: Trastuzumab w/o concurrent endocrine therapy in luminal HER2-positive metastatic breast cancer resulted in decreased overall survival
Title: Real world data: Trastuzumab w/o concurrent endocrine therapy in luminal HER2-positive metastatic breast cancer resulted in decreased overall survival
Authors: Šusnjar, Snežana V  ; Popovic, Lazar S  ; Cvetanovic, Ana  ; Stanic, Nemanja S; Citic, J; Kolarov-Bjelobrk, Ivana N  ; Popovic, Marina  ; Nedovic, Nikola M; Stojanovic, Aleksandar; Matovina-Brko, Gorana;
Serović, Kristina; Milosavljevic, N; Mutrezani, Zafir; ...; Gavrilovic, Dusica; Radulovic, Sinisa S  ;
Issue Date: 2018
Publication: EUROPEAN JOURNAL OF CANCER. Meeting11th European Breast Cancer Conference (EBCC)
ISSN: 0959-8049 ; eISSN 1879-0852 European Journal of Cancer / EJC Search Idenfier
Publisher: Oxford : Elsevier Science Ltd
Type: Conference Paper
Collation: vol. 92 br. Supplement 3 str. S112-S112
DOI: 10.1016/S0959-8049(18)30561-6
WoS-ID: 000429103100303
URI: https://enauka.gov.rs/handle/123456789/817060
URL: https://www.sciencedirect.com/science/article/abs/pii/S0959804918305616
Metadata source: (Preuzeto iz Nasi u WoS)
M-category: 
34documentMNO za medicinske nauke (19.03.2025.)
M34

Altmetric
Dimensions
Unpaywall

Google ScholarTM

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.